Company / Depreciation & Amortization
LEXICON PHARMACEUTICALS, INC. Depreciation & Amortization History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$554.0K
FY2025
5-year range
$292.0K / $2.9M
FY2021-FY2025
Trend
+29.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 10 years, ranging from $292,000 in FY2023 to $5M in FY2013.
Based on SEC 10-K filings.
$554,000 in FY2025 with a 10-year CAGR of -15.1%.
Increased from $292,000 to $554,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -15.1%
Key checks
Key Insights
- In FY2025, depreciation & amortization increased 29.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2013.
- Lowest depreciation & amortization in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $554.0K | +29.7% |
| FY2024 | $427.0K | +46.2% |
| FY2023 | $292.0K | -90.0% |
| FY2019 | $2.9M | +42.7% |
| FY2018 | $2.1M | +182.8% |
| FY2017 | $727.0K | -62.3% |
| FY2016 | $1.9M | -32.7% |
| FY2015 | $2.9M | -31.7% |
| FY2014 | $4.2M | -14.3% |
| FY2013 | $4.9M | -9.4% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026